Bayesian Statistics of Efficacy of the Pfizer-BioNTech COVID-19 Vaccine — part I Vaccine Efficacy and Beta-binomial model Bartek Skorulski Posterior distribution with 95% Credible Interval: (90.8–97.9%) ,,,,,,,,,our results are that the vaccine efficacy is 95% with 95%-Credible Interval equal to (90.8–97.9%). You can get slightly different results but they should be very close. Those results…
Mammals can breathe through their intestines By Nikk Ogasa On a good day, things exit through the anus. But in rodents and pigs in respiratory distress, oxygen can be absorbed by tissues in the rectum, helping the animals recover, a new study suggests. The scientists behind the research propose that flushing oxygen into the rectum could…
The Gentlest of Introductions to Bayesian Data Analysis How to think in a natural way based on data Michał Oleszak If you have ever taken a statistics class at university or an online course, you might recall terms such as hypothesis testing, confidence intervals, or p-values. If so, what you were taught was the so-called…
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews Matthew J. Page et al. Abstract The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past…
Excess Deaths From COVID-19 and Other Causes in the US, March 1, 2020, to January 2, 2021 Steven H. Woolf et al. A study analyzing US mortality in March-July 2020 reported a 20% increase in excess deaths, only partly explained by COVID-19. Surges in excess deaths varied in timing and duration across states and were…
Evaluation of the Clinical Benefit of Cancer Drugs Submitted for Reimbursement Recommendation Decisions in Canada Daniel E. Meyers et al. IMPORTANCE Cancer drugs approved by the US Food and Drug Administration have come under scrutiny for marginal clinical benefits; however, the clinical benefits of cancer drugs recommended for reimbursement in Canada have not been adequately…